Related Experiment Video
Updated: Mar 9, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway
Paul Fineran1, Emyr Lloyd-Evans1,2, Nathan A Lack1,3
1Department of Pharmacology, University of Oxford, Oxford, UK.
Background:
Tuberculosis remains a major global health concern. The ability to prevent phagosome-lysosome fusion is a key mechanism by which intracellular mycobacteria, including Mycobacterium tuberculosis, achieve long-term persistence within host cells. The mechanisms underpinning this key intracellular pro-survival strategy remain incompletely understood. Host macrophages infected with persistent mycobacteria share phenotypic similarities with cells taken from patients suffering from Niemann-Pick Disease Type C (NPC), a rare lysosomal storage disease in which endocytic trafficking defects and lipid accumulation within the lysosome lead to cell dysfunction and cell death. We investigated whether these shared phenotypes reflected an underlying mechanistic connection between mycobacterial intracellular persistence and the host cell pathway dysfunctional in NPC.
Methods:
The induction of NPC phenotypes in macrophages from wild-type mice or obtained from healthy human donors was assessed via infection with mycobacteria and subsequent measurement of lipid levels and intracellular calcium homeostasis. The effect of NPC therapeutics on intracellular mycobacterial load was also assessed.
Results:
Macrophages infected with persistent intracellular mycobacteria phenocopied NPC cells, exhibiting accumulation of multiple lipid types, reduced lysosomal Ca2+ levels, and defects in intracellular trafficking. These NPC phenotypes could also be induced using only lipids/glycomycolates from the mycobacterial cell wall. These data suggest that persistent intracellular mycobacteria inhibit the NPC pathway, likely via inhibition of the NPC1 protein, and subsequently induce altered acidic store Ca2+ homeostasis. Reduced lysosomal calcium levels may provide a mechanistic explanation for the reduced levels of phagosome-lysosome fusion in mycobacterial infection. Treatments capable of correcting defects in NPC mutant cells via modulation of host cell calcium were of benefit in promoting clearance of mycobacteria from infected host cells.
Conclusion:
These findings provide a novel mechanistic explanation for mycobacterial intracellular persistence, and suggest that targeting interactions between the mycobacteria and host cell pathways may provide a novel avenue for development of anti-TB therapies.
Insights
Mycobacterium tuberculosis prevents phagosome-lysosome fusion by mimicking Niemann-Pick Disease Type C (NPC) cellular defects. Targeting NPC pathway interactions offers a new strategy for tuberculosis treatment.
Area of Science:
- Cell Biology
- Microbiology
- Immunology
Background:
- Tuberculosis (TB) persistence relies on preventing phagosome-lysosome fusion within host cells.
- Mycobacterium tuberculosis (Mtb) infection shares cellular phenotypes with Niemann-Pick Disease Type C (NPC), a lysosomal storage disorder.
- Understanding this link may reveal novel Mtb survival mechanisms.
Purpose of the Study:
- To investigate the mechanistic connection between Mtb persistence and the host cell NPC pathway.
- To determine if Mtb induces NPC-like defects in macrophages.
- To assess the therapeutic potential of targeting this pathway.
Main Methods:
- Assessed NPC phenotypes (lipid accumulation, calcium homeostasis, trafficking) in Mtb-infected macrophages from mice and humans.
- Investigated the role of mycobacterial cell wall components.
- Evaluated the efficacy of NPC therapeutics against intracellular Mtb.
Main Results:
- Mtb-infected macrophages exhibited NPC-like phenotypes: lipid accumulation, reduced lysosomal calcium, and trafficking defects.
- Mycobacterial lipids alone induced these NPC phenotypes.
- Mtb likely inhibits the NPC1 protein, disrupting calcium homeostasis and phagosome-lysosome fusion.
- NPC therapeutics targeting calcium modulation aided Mtb clearance.
Conclusions:
- Mtb utilizes host NPC pathway defects for intracellular persistence.
- Targeting the interaction between Mtb and host NPC pathways presents a novel therapeutic strategy for TB.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...

